Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Moriceau

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
La Revue Du Praticien|December 5, 2018
Benoîte Mery, Guillaume Moriceau, Romain Rivoirard, et al.
La Revue Du Praticien|December 5, 2018
Benoîte Mery, Guillaume Moriceau, Romain Rivoirard, et al.
Journal of Medical Case Reports|November 27, 2018
Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reportsSylvie Négrier, Guillaume Moriceau, Valéry Attignon, et al.
Macromolecular Rapid Communications|September 15, 2021
Photonic Particles Made by the Confined Self-Assembly of a Supramolecular Comb-Like Block CopolymerGuillaume Moriceau, Cédric Kilchoer, Kenza Djeghdi, et al.
Oncotarget|November 6, 2015
Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot studyGuillaume Moriceau, Aurélie Bourmaud, Fabien Tinquaut, et al.
Chemotherapy|May 23, 2015
The Combination of 80 Years of Age and Metastatic Castration-Resistant Prostate Cancer Remain an Uphill Battle: A Case Report with Cabazitaxel as a Double-Edged SwordBenoite Méry, Jane-Chloé Trone, Guillaume Moriceau, et al.
Chemotherapy|January 12, 2016
Real-World Outcomes of Combination Chemotherapy with Trabectedin plus Pegylated Liposomal Doxorubicin in Patients with Recurrent Ovarian Cancer: A Single-Center ExperienceGuillaume Moriceau, Romain Rivoirard, Benoîte Méry, et al.
Chemotherapy|January 13, 2016
Translating Clinical Evidence-Based Medicine into the Real World: Single-Center Experience with Cabazitaxel in Metastatic Prostate Cancer PatientsGuillaume Moriceau, Aline Guillot, Cécile Pacaut, et al.
American Journal of Clinical Oncology|June 12, 2013
Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapyCécile Pacaut, Aurélie Bourmaud, Romain Rivoirard, et al.
Journal of Neuro-Oncology|April 10, 2021
Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screeningValentine Ruste, Marie Pierre Sunyach, Ronan Tanguy, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|December 5, 2018
Benoîte Mery, Guillaume Moriceau, Romain Rivoirard, et al.
La Revue Du Praticien|December 5, 2018
Benoîte Mery, Guillaume Moriceau, Romain Rivoirard, et al.
Journal of Medical Case Reports|November 27, 2018
Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reportsSylvie Négrier, Guillaume Moriceau, Valéry Attignon, et al.
Macromolecular Rapid Communications|September 15, 2021
Photonic Particles Made by the Confined Self-Assembly of a Supramolecular Comb-Like Block CopolymerGuillaume Moriceau, Cédric Kilchoer, Kenza Djeghdi, et al.
Oncotarget|November 6, 2015
Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot studyGuillaume Moriceau, Aurélie Bourmaud, Fabien Tinquaut, et al.
Chemotherapy|May 23, 2015
The Combination of 80 Years of Age and Metastatic Castration-Resistant Prostate Cancer Remain an Uphill Battle: A Case Report with Cabazitaxel as a Double-Edged SwordBenoite Méry, Jane-Chloé Trone, Guillaume Moriceau, et al.
Chemotherapy|January 12, 2016
Real-World Outcomes of Combination Chemotherapy with Trabectedin plus Pegylated Liposomal Doxorubicin in Patients with Recurrent Ovarian Cancer: A Single-Center ExperienceGuillaume Moriceau, Romain Rivoirard, Benoîte Méry, et al.
Chemotherapy|January 13, 2016
Translating Clinical Evidence-Based Medicine into the Real World: Single-Center Experience with Cabazitaxel in Metastatic Prostate Cancer PatientsGuillaume Moriceau, Aline Guillot, Cécile Pacaut, et al.
American Journal of Clinical Oncology|June 12, 2013
Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapyCécile Pacaut, Aurélie Bourmaud, Romain Rivoirard, et al.
Journal of Neuro-Oncology|April 10, 2021
Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screeningValentine Ruste, Marie Pierre Sunyach, Ronan Tanguy, et al.
Pageof 3